A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer

被引：0
|
作者：
Sivalingam, Vanitha [1 ]
McVey, Rhona [2 ]
Gilmour, Kyle [3 ]
Ali, Saad [4 ]
Roberts, Chris [5 ]
Renehan, Andrew [1 ,6 ]
Kitchener, Henry [1 ]
Crosbie, Emma [1 ]
机构：
[1] Univ Manchester, Inst Canc Sci, Manchester M20 4XW, Lancs, England
[2] Cent Manchester Univ Hosp Fdn Trust, Dept Histopathol, Manchester, Lancs, England
[3] Tameside Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Manchester, Lancs, England
[4] Royal Oldham Hosp, Dept Obstet & Gynaecol, Manchester, Lancs, England
[5] Univ Manchester, Inst Populat Hlth, Manchester M20 4XW, Lancs, England
[6] Christie NHS Fdn Trust, Dept Surg, Manchester, Lancs, England
来源：
LANCET | 2015年 / 385卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [1] Pre-surgical window study of metformin in obesity-driven endometrial cancer
    Sivalingam, V. N.
    McVey, R.
    Kitson, S.
    Gilmour, K.
    Ali, S.
    Roberts, C.
    Renehan, A. G.
    Kitchener, H.
    Crosbie, E. J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 18 - 18
  • [2] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Sullivan, S. A.
    Tran, A. M.
    Clark, L. H.
    Bateman, N. W.
    Hood, B. L.
    Conrads, T. P.
    Lee, D.
    Zhou, C.
    Makowski, L.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 21 - 22
  • [3] Reversal of obesity-driven aggressiveness of endometrial cancer by metformin
    Guo, Hui
    Kong, Weimin
    Zhang, Lu
    Han, Jianjun
    Clark, Leslie H.
    Yin, Yajie
    Fang, Ziwei
    Sun, Wenchuan
    Wang, Jiandong
    Gilliam, Timothy P.
    Lee, Douglas
    Makowski, Liza
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (10): : 2170 - 2193
  • [4] Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study
    Curigliano, G.
    Gomez Pardo, P.
    Meric-Bernstam, F.
    Conte, P.
    Lolkema, M. P.
    Beck, J. T.
    Bardia, A.
    Martinez Garcia, M.
    Penault-Llorca, F.
    Dhuria, S.
    Tang, Z.
    Solovieff, N.
    Miller, M.
    Di Tomaso, E.
    Hurvitz, S. A.
    BREAST, 2016, 28 : 191 - 198
  • [5] Surgical window-of-opportunity study of megestrol acetate compared with megestrol acetate and metformin for endometrial intraepithelial neoplasia
    Xu, Yanfei
    Saiz, Allison
    Rimel, Bj
    Corr, Bradley
    Secord, Angeles Alvarez
    Clark, Leslie Horn
    Kocherginsky, Masha
    Schering, Tia
    Benante, Kelly A.
    Kalinichenko, Kiril
    Sauter, Edward
    Samimi, Goli
    Dimond, Eileen
    Khan, Seema Ahsan
    Barber, Emma Longley
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
    Njoku, Kelechi
    Campbell, Amy E.
    Geary, Bethany
    MacKintosh, Michelle L.
    Derbyshire, Abigail E.
    Kitson, Sarah J.
    Sivalingam, Vanitha N.
    Pierce, Andrew
    Whetton, Anthony D.
    Crosbie, Emma J.
    CANCERS, 2021, 13 (04) : 1 - 25
  • [7] Drug repurposing of topiramate in obesity-driven endometrial cancer
    Tran, Arthur-Quan
    Sullivan, Stephanie A.
    Zhou, Chunxiao
    Kaufman, David
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [8] Obesity-driven endometrial cancer: is weight loss the answer?
    MacKintosh, M. L.
    Crosbie, E. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (07) : 791 - 794
  • [9] Orlistat as a novel targeted therapy for obesity-driven endometrial cancer
    Sullivan, Stephanie
    Tran, Arthur-Quan
    Wysham, Weiya
    Gehrig, Paola
    Zhou, Chunxiao
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [10] A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer
    Duska, Linda R.
    Petroni, Gina R.
    Lothamer, Heather
    Faust, William, Jr.
    Beumer, Jan H.
    Christner, Susan M.
    Mills, Anne M.
    Fracasso, Paula M.
    Parsons, Sarah J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 473 - 482
12345